Analysis of effluent
AssigneeDroplet Biosciences, Inc.
InventorWendy Winckler Adamovich
Life of this patent
Estimating the term…
Abstract
The invention provides methods of detecting, or predicting the aggressiveness of, a tumor by measuring cancer biomarkers in surgical drain fluid that may be collected from the site of a surgery such as a tumor resection or lymphadenectomy. Surgical drain fluid (SDF), and the lymph component of SDF in particular, contains biomarkers that demonstrably correlate to future cancer outcomes and that are thus predictive of the growth or aggressiveness of a tumor as well as surgical site infection and/or sepsis.
Claims20
A method for predicting onset of sepsis, the method comprising the steps of:
- obtaining lymphatic fluid;
- measuring a level of a microbial biomarker in the lymphatic fluid;
- and
- predicting sepsis onset on the basis of the measured level.
A method for detecting surgical site infection, the method comprising the steps of:
- obtaining lymphatic fluid from a surgical site;
- measuring a level of a microbial biomarker in the lymphatic fluid;
- and
- identifying a surgical site infection on the basis of the measured level.
Dependencies are inferred from the claim text.